BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell differentiation
,
Lung cancer
,
Kidney
,
Metabolism of nitric oxide
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
melan a
Summary
General Info
Curated Studies
Most Correlated Studies
Microarray analysis of the effects of ASP/MSH in melan-a melanocytes
Melanoma UKRV-Mel-15a cells resistant to MART-1
Melanocytes with inducible oncogenic receptor Xmrk stimulated with EGF
Skin layer-specific transcriptional profiles in normal and recessive yellow
Tumor, EBV or CMV-specific CD8+ T cells from melanoma patients
Explore Curated Studies Results
Literature
Most Relevant Literature
HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, …
Staged Excision of Lentigo Maligna of the Head and Neck: Assessing Surgical Excision Margins With Me…
Blood monocytes sample MelanA/MART1 antigen for long-lasting cross-presentation to CD8+ T cells afte…
Comparative genomic hybridization in a case of melanoma that loses expression of S100, HMB45, Melan …
Aberrant Melan-A Expression in Extramammary Paget Disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones
Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma
Melanated Group Midwifery Care (MGMC)
Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma
Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ